806 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 17 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
AC171558.1Predicted membrane proteins
CentrosomeTissue enriched
AC171558.2Predicted membrane proteins
Tissue enriched
ACKR2Atypical chemokine receptor 2G-protein coupled receptors
Predicted membrane proteins
Nucleoplasm
Vesicles
Cytosol
Tissue enhanced
ACKR3Atypical chemokine receptor 3Cancer-related genes
G-protein coupled receptors
Predicted membrane proteins
Vesicles
Plasma membrane
Renal cancer: 1.76e-6
Stomach cancer: 2.01e-4
Urothelial cancer: 2.93e-4
Cervical cancer: 4.64e-4
Expressed in all
ACKR4Atypical chemokine receptor 4G-protein coupled receptors
Predicted membrane proteins
Vesicles
Mitochondria
Mixed
ADCYAP1R1ADCYAP receptor type IG-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
VesiclesEndometrial cancer: 5.78e-4
Tissue enhanced
ADGRA1Adhesion G protein-coupled receptor A1G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADGRA2Adhesion G protein-coupled receptor A2G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 3.18e-7
Expressed in all
ADGRA3Adhesion G protein-coupled receptor A3G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ADGRB1Adhesion G protein-coupled receptor B1Cancer-related genes
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enriched
ADGRB2Adhesion G protein-coupled receptor B2G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
CentrosomeLung cancer: 4.02e-5
Breast cancer: 6.46e-4
Tissue enriched
ADGRB3Adhesion G protein-coupled receptor B3G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enriched
ADGRD1Adhesion G protein-coupled receptor D1G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Nucleus
Cytosol
Liver cancer: 9.27e-4
Tissue enhanced
ADGRD2Adhesion G protein-coupled receptor D2G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADGRE1Adhesion G protein-coupled receptor E1G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ADGRE2Adhesion G protein-coupled receptor E2CD markers
G-protein coupled receptors
Predicted membrane proteins
VesiclesRenal cancer: 4.35e-6
Tissue enhanced
ADGRE3Adhesion G protein-coupled receptor E3G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ADGRE5Adhesion G protein-coupled receptor E5CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
CytosolRenal cancer: 1.87e-6
Liver cancer: 3.73e-5
Expressed in all
ADGRF1Adhesion G protein-coupled receptor F1G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 1.35e-5
Tissue enhanced
ADGRF2Adhesion G protein-coupled receptor F2G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADGRF3Adhesion G protein-coupled receptor F3G-protein coupled receptors
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Not detected
ADGRF4Adhesion G protein-coupled receptor F4G-protein coupled receptors
Predicted membrane proteins
MitochondriaPancreatic cancer: 5.52e-4
Group enriched
ADGRF5Adhesion G protein-coupled receptor F5G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Renal cancer: 8.84e-5
Tissue enhanced
ADGRG1Adhesion G protein-coupled receptor G1Disease related genes
G-protein coupled receptors
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 5.52e-7
Head and neck cancer: 2.53e-4
Expressed in all
ADGRG2Adhesion G protein-coupled receptor G2Disease related genes
G-protein coupled receptors
Plasma proteins
Potential drug targets
Predicted membrane proteins
Plasma membrane
Cytosol
Tissue enriched
ADGRG3Adhesion G protein-coupled receptor G3G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Group enriched
ADGRG4Adhesion G protein-coupled receptor G4G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ADGRG5Adhesion G protein-coupled receptor G5G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Nuclear membrane
Vesicles
Cervical cancer: 4.25e-4
Tissue enhanced
ADGRG6Adhesion G protein-coupled receptor G6Disease related genes
G-protein coupled receptors
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Pancreatic cancer: 2.78e-5
Lung cancer: 8.78e-4
Tissue enhanced
ADGRG7Adhesion G protein-coupled receptor G7G-protein coupled receptors
Predicted membrane proteins
Group enriched
ADGRL1Adhesion G protein-coupled receptor L1G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Pancreatic cancer: 1.14e-4
Renal cancer: 4.45e-4
Tissue enhanced
ADGRL2Adhesion G protein-coupled receptor L2G-protein coupled receptors
Predicted membrane proteins
Plasma membrane
Cell Junctions
Endometrial cancer: 1.33e-4
Stomach cancer: 3.00e-4
Liver cancer: 9.92e-4
Mixed
ADGRL3Adhesion G protein-coupled receptor L3G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ADGRL4Adhesion G protein-coupled receptor L4G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 1.60e-4
Mixed
ADORA1Adenosine A1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
ADORA2AAdenosine A2a receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ADORA2BAdenosine A2b receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
CytosolMixed
ADORA3Adenosine A3 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
ADRA1AAdrenoceptor alpha 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRA1BAdrenoceptor alpha 1BCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneRenal cancer: 1.40e-6
Thyroid cancer: 3.19e-5
Endometrial cancer: 6.00e-5
Ovarian cancer: 2.67e-4
Glioma: 6.07e-4
Tissue enhanced
ADRA1DAdrenoceptor alpha 1DFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ADRA2AAdrenoceptor alpha 2AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Endometrial cancer: 8.06e-4
Mixed
ADRA2BAdrenoceptor alpha 2BPredicted membrane proteins
Mixed
ADRA2CAdrenoceptor alpha 2CFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRB1Adrenoceptor beta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
ADRB2Adrenoceptor beta 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
CytosolRenal cancer: 3.15e-9
Mixed
ADRB3Adrenoceptor beta 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
AGTR1Angiotensin II receptor type 1Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
AGTR2Angiotensin II receptor type 2G-protein coupled receptors
Predicted membrane proteins
Group enriched
APH1BAph-1 homolog B, gamma-secretase subunitPredicted membrane proteins
Pancreatic cancer: 1.05e-4
Renal cancer: 2.25e-4
Tissue enhanced
Page of 17 | next »